Orchard Therapeutics has revealed its US pricing plans for Lenmeldy, its gene therapy for metachromatic leukodystrophy (MLD), placing a $4.25 million price tag on the one-shot treatment.

The top 10 US bank logos demonstrate how thoughtful and strategic design can communicate values, build trust, and leave an impression. A company's logo serves as the face of its brand, encapsulating ...